Zylox-Tonbridge, a Hong Kong-listed company specialising in neurovascular and peripheral vascular interventional products, has agreed to acquire German medical technology company Optimed. Under the ...

HANGZHOU, China and BERLIN, Jan. 16, 2026 /PRNewswire/ -- Zylox-Tonbridge (HKEX:2190), a Hong Kong-listed medical technology company focused on neuro-and peripheral vascular interventional products ...

OptiMed Health Partners celebrates receiving the Pioneer in Performance Measurement Award from URAC (Utilization Review Accreditation Commission). Organizations that make key contributions to advance ...

SAN FRANCISCO--(BUSINESS WIRE)--OptiMed Health Partners, has named Vida Health, a leader in virtual cardiometabolic care, as a preferred partner for providing personalized virtual cardiometabolic care ...

WELLESLEY, Mass., July 26, 2023 /PRNewswire/ -- Sun Life U.S., the largest independent medical stop-loss provider in the country, has named OptiMed Health Partners as a preferred partner to further ...

About SPRAVATO® Treatment: SPRAVATO®, also known as esketamine, represents a novel approach to treating TRD, offering new hope to individuals who have not responded to conventional antidepressant ...

ATLANTA, Dec. 14, 2020 /PRNewswire/ -- OptiMed Health Plans has developed secure online website portals as part of its ongoing digital solutions strategy to make health coverage more user-friendly.

BUFFALO, N.Y. – The University at Buffalo School of Dental Medicine and university spinoff OptiMed Technology were awarded a $50,000 manufacturing grant from the Jeff Lawrence Innovation Fund to ...

OptiMed Technologies Pty has been appointed as the exclusive distributor for The Insides Company’s therapeutic chyme reinfusion solutions for Australia. Garth Sutherland, CEO of The Insides Company ...

The MarketWatch News Department was not involved in the creation of this content. OptiMed to support Vida's full suite of cardiometabolic solutions including clinical obesity management, providing a ...